|
Status |
Public on Jun 01, 2019 |
Title |
Gene expression analysis of human CD34+ AML cells cultured with or without gabapentin |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
To clarify the global gene expression alteration in primary CD34+ AML cells after BCAA metabolism inhibition, CD34+ AML cells were treated with or without gabapentin in vitro. After 9-12 hours of culture with or without gabapentin, FACS-purified CD34+ AML cells were subjected to transcriptome analysis.
|
|
|
Overall design |
To clarify how BCAA metabolism affect the gene expression of human CD34+ AML cells, CD34+ AML cells from 4 independent patients were treated with or without 40mM gabapentin, a specific BCAT1 inhibitor for 9-12 hours. After BCAA metabolism inhibition by gabapentin, CD34+ AML cells were purified and total RNA was extracted from control and treated samples.
|
|
|
Contributor(s) |
Kikushige Y, Akashi K |
Citation(s) |
36044390 |
Submission date |
Feb 26, 2019 |
Last update date |
Sep 22, 2022 |
Contact name |
Yoshikane Kikushige |
E-mail(s) |
kikusige@intmed1.med.kyushu-u.ac.jp
|
Organization name |
Kyushu University
|
Street address |
3-1-1 Maidashi, Higashiku
|
City |
Fukuoka |
ZIP/Postal code |
812-8582 |
Country |
Japan |
|
|
Platforms (1) |
GPL21185 |
Agilent-072363 SurePrint G3 Human GE v3 8x60K Microarray 039494 [Probe Name Version] |
|
Samples (8)
|
|
Relations |
BioProject |
PRJNA524297 |